Search results
18 sie 2021 · Nine categories of burning mouth syndrome treatment were identified: Anticonvulsant and antidepressant agents, phytomedicine and alpha lipoic acid supplements, low-level laser therapy, saliva substitute, transcranial magnetic stimulation, and cognitive behaviour therapy.
Initial treatments with nortriptyline hydrochloride and sertraline hydrochloride were contraindicated because of adverse effects, but the administration of gabapentin significantly reduced oral burning. The present case illustrates the effectiveness of gabapentin as a treatment of burning mouth syndrome.
21 sie 2019 · Gabapentin as an adjunctive drug could be more effective in reducing the severity of GI symptoms in patients with dyspepsia, especially neurological symptoms (such as pain, reflux, and indigestion). Keywords: Functional dyspepsia, gabapentin, gastrointestinal disorders. Go to: Introduction.
14 gru 2023 · Objective The aim of this retrospective study was to evaluate the effectiveness and safety of topical gabapentin solution (250 mg/mL) for the management of burning mouth syndrome (BMS).
Initial treatments with nortriptyline hydrochloride and sertraline hydrochloride were contraindicated because of adverse effects, but the administration of gabapentin significantly reduced oral burning.
30 wrz 2020 · Systemic treatments with gabapentin (1200 mg/day for over 26-32 weeks) and pregabalin (50-150 mg/day) showed efficacy in subjects with BMS [31,32].
Gabapentin has little or no effect in the treatment of burning mouth syndrome - results of an open-label pilot study. Eur J Neurol. 2006 Jul;13 (7):e6-7. doi: 10.1111/j.1468-1331.2006.01294.x. Authors. S M Heckmann , J G Heckmann , A Ungethüm , P Hujoel , T Hummel. PMID: 16834694. DOI: 10.1111/j.1468-1331.2006.01294.x. No abstract available.
